Title:
Digital-twin of bioreactor for accelerated design and optimal operations in production of complex biologics - mechanistic models to describe biological processes more realistically
Agreement Value:
$240,350.00
Agreement Date:
Mar 25, 2020 - Mar 24, 2023
Description:
Bioreactors play a major role in manufacturing processes of biologics. While their design has been well documented for traditional fermentations for production of simple biomolecules, their use for production of complex biologics using eukaryotic systems such as HEK-293 human cells remains very empirical. Biologics production in bioreactors is performed in a high dimensional design space requiring a high and broad level of expert knowledge not necessary captured systematically in the prevailing scientific and technical literature. Additionally, biological products such as exosomes and viral vectors (AAV) are complex biological structures that have demonstrated recently significant value in the treatment of a number of cancers and hereditary diseases. Their manufacturing in bioreactor at scale in quantity and quality that meets the preclinical and clinical needs significantly limits their use and growth potential as therapeutic tools. This creates an opportunity to integrate the expert knowledge accumulated in the databases and exploit the advances in AI to accelerate the design and optimization of the production of these two key biologics (exosomes and AAV) through the implementation and operation of a digital-twin bioreactor connected to a physical bioreactor using a series of sensors in constant communication and feed-back.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Montreal, Quebec, CA H3A 0G4
Reference Number:
172-2021-2022-Q4-947520
Report Type:
Grants and Contributions
Recipient Business Number:
119128981
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 240,350 dollars and the end date of this agreements has been modified by 358 days.
Amendment Date
Feb 8, 2022
Recipient's Legal Name:
The Royal Institution for the Advancement of Learning/McGill University
Federal Riding Name:
Ville-Marie–Le Sud-Ouest–Île-des-Sœurs
Federal Riding Number:
24077
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.